摘要
A panel of experts from 22 countries recently proposed a name change from nonalcoholic fatty liver disease(NAFLD)to metabolic-associated fatty liver disease,or MAFLD.1 Sub-sequently,new criteria for diagnosing MAFLD were provided to help guide clinicians in their clinical practice.2 The criteria are based on evidence of hepatic steatosis in the presence of one or more of overweight/obesity,type 2 diabetes,or metabolic dysregulation.3 The proposed novel diagnostic criteria represent a landmark in hepatology that combines our current understanding of obesity,metabolic syndrome and system biology into a single focus.
基金
the National Natural Science Foundation of China(82070588)
High Level Creative Talents from Department of Public Health in Zhejiang Province(S2032102600032)
Project of New Century 551 Talent Nurturing in Wenzhou.
